Edesa Biotech
EDSA
12 hedge funds and large institutions have $93K invested in Edesa Biotech in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
9% more funds holding
Funds holding: 11 → 12 (+1)
3% more capital invested
Capital invested by funds: $90K → $93K (+$3K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$50.4K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$19.8K |
| 3 |
VF
Virtu Financial
New York
|
+$8.9K |
| 4 |
AG
Advisor Group
Phoenix,
Arizona
|
+$6.43K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.24K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$40K |
| 2 |
Renaissance Technologies
New York
|
-$40K |
| 3 |
CFD
Creative Financial Designs
Kokomo,
Indiana
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $49K | +$50.4K | +204 | New |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $19K | +$19.8K | +80 | New |
|
|
VF
3
Virtu Financial
New York
| $9K | +$8.9K | +36 | New |
|
|
AG
4
Advisor Group
Phoenix,
Arizona
| $7K | +$6.43K | +26 | +650% |
|
|
5
UBS Group
Zurich,
Switzerland
| $5K | +$1.24K | +5 | +29% |
|
6
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | – | – | – |
|
|
ASN
7
Advisory Services Network
Atlanta,
Georgia
| $1K | – | – | – |
|
|
WAS
8
WESPAC Advisors SoCal
Pasadena,
California
| $1K | – | – | – |
|
|
9
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$40K | -169 | Closed |
|
|
10
Renaissance Technologies
New York
| – | -$40K | -169 | Closed |
|
|
CFD
11
Creative Financial Designs
Kokomo,
Indiana
| – | -$1K | -3 | Closed |
|
12
Credit Agricole
Montrouge Cedex,
France
| – | +$247 | +1 | New |
|
EDSA Hedge Fund Activity: Q1 2018 in Review
12 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q1 2018, worth a combined $93K — up 3.3% from $90K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new EDSA positions and 3 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $50.4K. The largest seller was Deutsche Bank, exiting entirely with an estimated $40K sold.
- 12 institutional investors held Edesa Biotech (EDSA) as of Q1 2018, up from 11 in Q4 2017.
- Funds reported $93K of Edesa Biotech stock for Q1 2018, up 3.3% quarter-over-quarter.
- 4 funds opened new Edesa Biotech positions in Q1 2018 and 3 closed out, a net change of +1 holder.
- The largest Edesa Biotech buyer in Q1 2018 was Citadel Advisors, an estimated $50.4K added.
- The largest Edesa Biotech seller in Q1 2018 was Deutsche Bank, an estimated $40K sold.
Based on aggregated 13F filings for Q1 2018.